Galectin (GALT) Posts Q2 Loss of 17c/Share

Galectin (NASDAQ: GALT) reported Q2 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Galectin (GALT) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• United Community Banks sells equipment finance unit for $1.9 billion
• Aspire Biopharma to acquire automotive supplier for $30 million